This supports the hypothesis that hyperglycemia-induced impairment in insulin signaling exacerbates neuroinflammation and tau pathology and is in line with previous studies showing a link between metabolic dysfunction and cognitive impairment in diabetes. Here, MAPT is linked to diabetes mellitus.